Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-31 @ 9:59 AM
Study NCT ID:
NCT02217904
Status:
COMPLETED
Last Update Posted:
2019-08-12
First Post:
2014-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Islatravir (MK-8591) in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus-1 Infected Participants (MK-8591-003)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-17
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-11
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-13
First Submit QC Date:
None
Study First Post Date:
2014-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-02
Results First Submit QC Date:
None
Results First Post Date:
2018-12-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-24
Last Update Post Date:
2019-08-12
Last Update Post Date Type:
ACTUAL